Dronedarone

CAS 141626-36-0 1 current recordSmall Molecule

Who holds supplier records for Dronedarone? 1 organisation holds a current record for Dronedarone: an active US FDA Type II Drug Master File. Recorded organisation countries for current records: France (1).

Most records are filed under another form of this substance: Dronedarone Hydrochloride (17 current sources). A DMF or CEP is listed under the form it names.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Dronedarone: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/dronedarone

Reading the evidence

  • One current record

    One organisation holds a current DMF or CEP. A record shows a regulatory filing, not current commercial availability or a qualified source for your product.

  • No company-level GMP certificate matched

    No current EU or UK GMP certificate was matched to these organisations. That is not a negative finding; ask each candidate for its certificate and latest inspection outcome.

  • US product patents listed

    The latest patent listed in the FDA Orange Book for an approved product containing Dronedarone expires 30 Jun 2031. Product, formulation and method-of-use patents do not by themselves stop the ingredient being supplied or other products being approved.

Current records (1)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Dronedarone. Country is the organisation's recorded country, not necessarily the manufacturing site.

Need Dronedarone sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

US product patents and exclusivity

The FDA Orange Book lists patents and exclusivities for specific approved products (1 listed product contain Dronedarone). The latest listed patent expires 30 Jun 2031. These dates are product-specific: they can cover a formulation, a combination or a method of use, and do not on their own show whether the ingredient is protected or whether generics are already approved. Check the individual product entries before planning a launch.

Other forms of this substance

A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:

Overview

Dronedarone is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL184412).

Chemical identity

IUPAC name
N-[2-butyl-3-[4-[3-(dibutylamino)propoxy]benzoyl]-1-benzofuran-5-yl]methanesulfonamide
Canonical SMILES
CCCCC1=C(C2=C(O1)C=CC(=C2)NS(=O)(=O)C)C(=O)C3=CC=C(C=C3)OCCCN(CCCC)CCCC
InChIKey
ZQTNQVWKHCQYLQ-UHFFFAOYSA-N
Synonyms
Dronedarona, Dronedarone, SR-33589, SR33589, SR 33589, SR 33589B, CHEBI:50659, dronedaronum, RefChem:55073, Multaq, Dronedarone [INN], Dronedarone (INN)

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Antiarrhythmic
Mechanism of action
Cytochrome P450 2D6 Inhibitors; Cytochrome P450 3A Inhibitors; P-Glycoprotein Inhibitors

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Dronedarone?

1 organisation holds an active US FDA Type II Drug Master File or a CEP for Dronedarone: CHEMWERTH INC (France). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Dronedarone Drug Master Files are active?

CHEMWERTH INC (DMF 26479). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

Does the FDA Orange Book list patents for products containing Dronedarone?

Yes. The latest patent listed for an approved US product containing Dronedarone expires 30 Jun 2031, across 1 listed products. These patents protect specific products, formulations or uses. They do not by themselves mean the ingredient is protected, and generic versions of other products may already be approved.

How do I qualify a Dronedarone supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Dronedarone?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.